Ovarian Cancer Early Detection Screening Program

Ovarian Screening

While survival rates for other women’s cancers – like breast and cervical cancer – have dramatically improved in recent years, the incidence and mortality of ovarian cancer has remained relatively unchanged in the past 50 years.

When caught in its earliest stages, survival rates for ovarian cancer can be as high as 90 percent. Regrettably, however, early symptoms are difficult to diagnose, are often misdiagnosed, or go undetected. This leads to 75% of all ovarian cancer patients being diagnosed in advanced stages when the disease is more difficult to treat. Improvement in clinical early detection is critical to changing these sobering statistics.

The Rivkin Center’s Ovarian Cancer Early Detection Screening Program serves as a model for other programs across the nation serving women determined at high-risk for developing ovarian cancer. The program provides women with the most advanced screening tests currently available, while also providing researchers the tools to identify and discover new techniques to detect ovarian cancer at its earliest stages.

“This program is so important not only because it gives me the opportunity to provide researchers with information they need to further their research in early detection, but because it offers me a ‘safety net’ for my own health. I had no second thoughts about participating – the choice was obvious.” - Rachel Prouser Marenstein, Ovarian Cancer Early Detection Screening Program Participant